 IRVINE, Calif., June 15, 2021 GLOBE NEWSWIRE -- Biomerica, Inc. NASDAQ: BMRA today announced that the Mexican Patent Office has issued a notice of allowance for Biomericas patent application pertaining to the Companys InFoods technology platform that offers a revolutionary approach in the treatment of patients suffering from Irritable Bowel Syndrome IBS. Specifically, this allowed application contains claims that broadly cover the method that enables physicians to identify patient specific foods, such as milk, shrimp, broccoli, etc., that, when removed from the patients diet, may alleviate or improve an individuals IBS symptoms, including constipation, diarrhea, bloating, severe cramping, pain and indigestion. 